Ming-Chung Wang Selected Research

Ming-Chung Wang Research Topics

Disease

5	Hepatitis B 12/2021 - 01/2002
5	Hepatitis 12/2021 - 01/2002
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021 - 01/2002
5	Neoplasms (Cancer) 01/2018 - 03/2008
4	Multiple Myeloma 01/2022 - 03/2010
4	Infections 12/2021 - 01/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 03/2010
4	Lymphoma (Lymphomas) 01/2021 - 03/2008
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 06/2007
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2019 - 12/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2014 - 03/2010
2	Thrombocytopenia (Thrombopenia) 10/2014 - 03/2010
1	Hemolysis 05/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Fibrosis (Cirrhosis) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2017
1	Citrullinemia 12/2017
1	Skin Diseases (Skin Disease) 03/2016
1	Lymphadenopathy 03/2016
1	Erectile Dysfunction 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2015
1	Hemorrhage 12/2015
1	Splenomegaly 07/2015
1	Primary Myelofibrosis (Myelosclerosis) 07/2015
1	Albuminuria 04/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2015
1	Anemia 04/2015
1	Lymphopenia (Lymphocytopenia) 10/2014
1	Asthenia 10/2014
1	Fatigue 10/2014
1	Cytopenia 01/2014
1	Epstein-Barr Virus Infections 01/2013
1	Disease Progression 01/2013
1	Leukemia 11/2011

Drug/Important Bio-Agent (IBA)

6	Rituximab (Mabthera)FDA Link 12/2021 - 03/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 10/2014
3	Hemoglobins (Hemoglobin)IBA 05/2021 - 04/2015
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2014 - 01/2002
3	Lamivudine (Epivir)FDA Link 03/2010 - 01/2002
2	AntibodiesIBA 12/2021 - 07/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2014
2	Immunoglobulin G (IgG)IBA 01/2018 - 03/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 01/2014
2	Bortezomib (Velcade)FDA Link 10/2014 - 03/2010
2	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 11/2011
1	pomalidomideIBA 01/2022
1	isatuximabIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 05/2021
1	Protein CIBA 05/2021
1	Antithrombin IIIIBA 05/2021
1	Biological ProductsIBA 05/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Monoclonal AntibodiesIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	copanlisibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	FibrinIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Arginine (L-Arginine)FDA Link 12/2017
1	arginine deiminaseIBA 12/2017
1	ADI PEG20IBA 12/2017
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 12/2017
1	Lenalidomide (CC 5013)FDA Link 09/2017
1	AutoantibodiesIBA 03/2016
1	Interferon-gamma (Interferon, gamma)IBA 03/2016
1	Inosine Triphosphate (ITP)IBA 12/2015
1	eltrombopag FDA Link 12/2015
1	Glycoproteins (Glycoprotein)IBA 12/2015
1	Thrombopoietin ReceptorsIBA 12/2015
1	Bendamustine Hydrochloride FDA Link 12/2015
1	Janus Kinase InhibitorsIBA 07/2015
1	Janus Kinase 1IBA 07/2015
1	ruxolitinibIBA 07/2015
1	Erythropoietin FDA Link 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2015
1	Serum AlbuminIBA 04/2015
1	PanobinostatIBA 10/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014
1	DNA (Deoxyribonucleic Acid)IBA 06/2014
1	Antiviral Agents (Antivirals)IBA 06/2014
1	Alanine Transaminase (SGPT)IBA 06/2014
1	Prednisolone (Predate)FDA LinkGeneric 06/2014
1	Vincristine (Oncovin)FDA LinkGeneric 06/2014
1	entecavir FDA Link 06/2014
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Tyrosine Kinase InhibitorsIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 11/2011
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2011
1	CateninsIBA 11/2011
1	CarcinogensIBA 11/2011
1	Tyrosine (L-Tyrosine)FDA Link 02/2011

Therapy/Procedure

11	Therapeutics 12/2021 - 01/2002
7	Drug Therapy (Chemotherapy) 12/2021 - 01/2002
1	Intravenous Infusions 01/2021
1	Aftercare (After-Treatment) 12/2015